Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Inflammatory Response01:28

Inflammatory Response

2.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nitazoxanide reduced inflammatory markers and mitochondrial changes in human retinal endothelial cells grown in high glucose.

Molecular vision·2026
Same author

Inhibition of sortilin reduces neuronal and vascular damage after ischemia/reperfusion through reduced inflammatory and autophagy actions in retinal Müller cells.

Molecular vision·2026
Same author

Caveolin-1 regulates inflammatory mediators in retinal endothelial cells.

Molecular vision·2025
Same author

EphB1 causes retinal damage through inflammatory pathways in the retina and retinal Müller cells.

Molecular vision·2024
Same author

Semaphorin 7a regulates inflammatory mediators and permeability in retinal endothelial cells.

Microvascular research·2023
Same author

Epac1 and PKA agonists inhibit ROS to reduce NLRP3 inflammasome proteins in retinal endothelial cells.

Molecular vision·2023

Related Experiment Video

Updated: Jun 30, 2025

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases
06:51

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases

Published on: December 9, 2022

4.1K

Ephrin B1 Regulates Inflammatory Pathways in Retinal Müller Cells.

Li Liu1, Youde Jiang1, Mohamed Al-Shabrawey2,3

  • 1Department of Ophthalmology, Visual and Anatomical Sciences, Wayne State University School of Medicine, Detroit, MI 48201, USA.

Journal of Diabetes and Clinical Research
|March 19, 2024
PubMed
Summary
This summary is machine-generated.

Ephrin B1 in retinal Müller cells drives inflammation in diabetic retinopathy. Reducing ephrin B1 significantly decreased key inflammatory proteins, suggesting a potential therapeutic target for diabetic eye disease.

Keywords:
DiabetesEphrin B1InflammationMiceMüller cellsNLRP3Retina

More Related Videos

Müller Glia Cell Activation in a Laser-induced Retinal Degeneration and Regeneration Model in Zebrafish
06:27

Müller Glia Cell Activation in a Laser-induced Retinal Degeneration and Regeneration Model in Zebrafish

Published on: October 27, 2017

9.8K
Experimental Models for Study of Retinal Pigment Epithelial Physiology and Pathophysiology
08:28

Experimental Models for Study of Retinal Pigment Epithelial Physiology and Pathophysiology

Published on: November 6, 2010

19.3K

Related Experiment Videos

Last Updated: Jun 30, 2025

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases
06:51

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases

Published on: December 9, 2022

4.1K
Müller Glia Cell Activation in a Laser-induced Retinal Degeneration and Regeneration Model in Zebrafish
06:27

Müller Glia Cell Activation in a Laser-induced Retinal Degeneration and Regeneration Model in Zebrafish

Published on: October 27, 2017

9.8K
Experimental Models for Study of Retinal Pigment Epithelial Physiology and Pathophysiology
08:28

Experimental Models for Study of Retinal Pigment Epithelial Physiology and Pathophysiology

Published on: November 6, 2010

19.3K

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Molecular Medicine

Background:

  • Inflammation is a known factor in diabetic retinopathy complications.
  • Upstream regulators of inflammatory factors in diabetic retinopathy remain poorly understood.

Purpose of the Study:

  • To investigate the role of ephrin B1 in retinal Müller cells.
  • To determine the effect of ephrin B1 on inflammatory protein expression in the context of diabetes.

Main Methods:

  • Analysis of ephrin B1 levels in human and mouse diabetic retinas and cultured Müller cells.
  • Generation of Müller cell specific ephrin B1 knockout mice.
  • Quantification of inflammatory proteins (HMGB1, NLRP3 pathway) in retinal lysates.

Main Results:

  • Ephrin B1 levels were significantly elevated in diabetic retinas and high-glucose cultured Müller cells.
  • Elimination of ephrin B1 in Müller cells resulted in a significant reduction of studied inflammatory proteins.
  • Data indicate a direct link between ephrin B1 and inflammatory pathways in diabetic retinopathy.

Conclusions:

  • Ephrin B1 is upregulated in the diabetic retina and influences key inflammatory pathways.
  • Targeting ephrin B1 in Müller cells may represent a novel therapeutic strategy for diabetic retinopathy.
  • Further research into ephrin B1 inhibition could lead to new treatments for diabetic eye disease.